Coding of Stroke and Stroke Risk Factors Using International Classification of Diseases, Revisions 9 and 10

Size: px
Start display at page:

Download "Coding of Stroke and Stroke Risk Factors Using International Classification of Diseases, Revisions 9 and 10"

Transcription

1 Coding of Stroke and Stroke Risk Factors Using International Classification of Diseases, Revisions 9 and 10 Rae A. Kokotailo, BSc; Michael D. Hill, MD, MSc, FRCPC Background and Purpose Surveillance is necessary to understand and meet the future demands stroke will place on health care. Administrative data are the most accessible data source for stroke surveillance in Canada. The International Classification of Diseases, 10th revision () coding system has potential improvements over for stroke classification. Our purpose was to compare hospital discharge abstract coding using and for stroke and its risk factors. Methods We took advantage of a switch in coding systems from to to independently review stroke patient charts. From time periods April 2000 to March 2001, 717 charts, and from April 2002 to March 2003, 249 charts were randomly selected for review. Using a before-and-after time period design, the accuracy of hospital coding of stroke (part I) and stroke risk factors (part II) using and was compared. We used careful definitions of stroke and its types based on using the fourth and fifth digit modifier codes. Results Stroke coding was equally good with (90% [CI to 93] correct) and [92% (CI to 95 correct) with. There were some differences in coding by stroke type, notably with transient ischemic attack, but these differences were not statistically significant. Atrial fibrillation, coronary artery disease/ischemic heart disease, diabetes mellitus, and hypertension were coded with high sensitivity (81% to 91%) and specificity (83% to 100%). was as good as for stroke risk factor coding. Conclusions Passive surveillance using administrative data are a useful tool for identifying stroke and its risk factors using both and. (Stroke. 2005;36: ) Key Words: epidemiology health services research stroke risk factors An impending surge of new stroke cases and associated costs are expected in Western countries from 2010 through 2030 as the 1945 to 1950 demographic reaches their seventh decade and ages thereafter. Surveillance is necessary to determine the future demands stroke will place on health care. 1,2 This should encompass stroke events and associated stroke risk factors. Such data will permit informed decision making regarding healthcare resource allocation to preventive and acute treatment programs. Unlike cancer and some infectious diseases, there is little active or passive surveillance of stroke and its risk factors. One advantage of passive surveillance using administrative data are that such data are readily available and are a cost-effective resource compared with active surveillance. This is particularly true in Canada, where a centralized administrative structure to health care exists. Administrative data have been used to quantify trends in stroke; however, it has been criticized for lack of accuracy with low sensitivity and specificity. 3 8 Furthermore, a particular disadvantage of administrative data are the inability to ascertain stroke severity, which is the most important short- and long-term prognostic variable. Nevertheless, stroke coding has been reviewed previously and found to be useful for high-level comparisons, particularly when compared against other diseases. We believe that a diagnostic accuracy of 85% is adequate for assessing trends over time. However, stroke risk factors have not been examined previously using administrative data, and validation of existing coding would enrich the utility of administrative data for surveillance of stroke. Before fiscal year 2002/2003, medical centers in Alberta used the International Classification of Diseases, 9th Revision (), Clinical Modifications to code hospital discharge abstracts. However, numerous studies have reported inaccuracies using. 2,3,7,9,10 At the beginning of 2002, the 10th revision replaced province-wide. Compared with, is qualitatively more intuitive and specific for the diagnosis of ischemic stroke. We sought to compare the proportion of correctly coded stroke patient charts in academic and community hospitals (part I) and to assess stroke risk factor coding (part II) using and via a before-after study design. Received March 12, 2005; final revision received April 10, 2005; accepted May 3, From the Calgary Stroke Program, Departments of Clinical Neurosciences (M.D.H., R.A.K.), Medicine (M.D.H.), and Community Health Sciences (M.D.H.), Faculty of Medicine, University of Calgary, Alberta, Canada. Both authors contributed equally to this work. Correspondence to Michael D. Hill, Associate Professor, Calgary Stroke Program, Department of Clinical Neurosciences, University of Calgary, Foothills Hospital, Room 1242A, th St NW, Calgary, Alberta, T2N 2T9, Canada. michael.hill@calgaryhealthregion.ca 2005 American Heart Association, Inc. Stroke is available at DOI: /01.STR a1 1776

2 Kokotailo and Hill Coding of Stroke Using and 1777 TABLE 1. ICD Stroke Codes* Stroke Type Code Definition Code Definition AIS Retinal vascular occlusion H34.1 Central retina artery occlusion 433.x1 Occlusion and stenosis of precerebral arteries I63.x Cerebral infarction 434.x1 Occlusion of cerebral arteries I64.x Stroke, not specified as hemorrhage or infarction 436 Acute, but ill-defined cerebrovascular disease ICH 431.x Intracerebral hemorrhage I61.x Intracerebral hemorrhage SAH 430.x Subarachnoid hemorrhage I60.x Subarachnoid hemorrhage TIA 435.x Transient cerebral ischemia G45.x Transient cerebral ischemic attacks and related syndromes *Excludes: 433.x0 (occlusion and stenosis of precerebral arteries without mention of cerebral infarction), 434.x0 (occlusion of cerebral arteries without mention of cerebral infarction), 437.x (other and ill-defined cerebrovascular disease), 438.x (late effects of cerebrovascular disease), I65.x (occlusion and stenosis of precerebral arteries not resulting in cerebral infarction), I66.x (occlusion and stenosis of cerebral arteries not resulting in cerebral infarction), I67.x (other cerebrovascular diseases), I69.x (sequellae of cerebrovascular disease), and G45.4 (transient global amnesia). These criteria are investigator derived. Methods Data used for parts I and II of this study were retrieved from a database of hospital discharge abstracts from the 3 adult acute care sites: a university hospital (Foothills Medical Centre) and 2 community hospitals (Peter Lougheed Centre and Rockyview General Hospital) in the Calgary health region. These sites serve a population of 1.4 million people. Data from the Alberta Children s Hospital were not considered in this study. Each of the 3 acute care sites house a computed tomography (CT) and MRI scanner. Data for this study included patients admitted as inpatients as well as patients seen at the emergency department and discharged without admission. It does not include patients who were seen in an outpatient clinic, physician s office, or those who did not present to medical attention. A single health records technologist conducted coding of hospital discharge abstracts at the university hospital. Before the study period, this person trained with the Calgary Stroke Team, learning more about stroke and its clinical diagnosis and management. Further, an ongoing dialogue exists between the health records department and the Calgary Stroke Team to resolve coding issues. At the 2 community hospitals, coding was not centralized to a single health records technologist. All patients with a discharge diagnosis ( codes 430.x, 431.x, 433.x1, 434.x1, 435.x, 436, and 362.3) of stroke were acquired for the 2000/2001 fiscal year (April to March); for the 2002/2003 fiscal year, codes I60.x, I61.x, I63.x, I64.x, H34.1, and G45.x were used to identify the patients. In, the fourth and fifth digits were used to exclude or include patients. In the intervening year, coding switched from to, and this time period between data collection epochs allowed for learning on the new system. All patients (n2529) with a diagnosis of stroke in the primary diagnostic position, implying that stroke was the most responsible diagnosis for length of stay, comprised the sampling frame. This approach has been shown to result in high specificity and positive predictive value (PPV). 3 A research assistant trained by a stroke neurologist in definitions of stroke and its risk factors performed the chart review. The neurologist resolved any ambiguities in diagnosis. The investigators accessed the same patient chart documents as health records technologists. If the chart contained multiple admissions, only those documents from the admission under review were used. Part I Major stroke types subarachnoid hemorrhage (SAH), intracerebral hemorrhage (ICH), acute ischemic stroke (AIS), and transient ischemic attack (TIA) were defined as described in Table 1. A stratified random sample of charts was drawn for review, stratified by major stroke type and by year. Sampling of AIS within the cohort was further oversampled compared with to allow for a better assessment of codes described as acute arterial occlusion without infarct. The size of the sample varied between 10% and 65% of the total available and was based on an expected precision of the sensitivity and specificity defined by a 10% 95% CI width. Patient charts were reviewed in detail. Physician history and physical examination notes, physician progress notes, CT and MRI imaging reports (if available), and discharge summaries were used to ascertain the diagnosis most responsible for hospital length of stay and to assign a code. The proportion of charts that were adjudicated with available imaging reports (CT or MRI) was determined. Strokes were coded as TIA if they resolved within 24 hours of onset, and if imaging was performed, no detectable changes were evident. Using our determination as the gold standard, the proportion correct of hospital health technologist coding of AIS, SAH, ICH, and TIA using and were then calculated and compared. For practical reasons, chart reviewers were not blinded to how the charts had been coded by the health records technologist. Statistical comparisons were made using Fisher s exact test, and all proportions are reported using exact CIs. It was not possible to assess the sensitivity and specificity for the diagnosis of stroke because nonstroke diagnoses were underrepresented by design. Instead, we report the PPV of coding by stroke type among patients with stroke as well the Kappa statistic () as a measure of the agreement between coder and researcher. The PPVs were arbitrarily categorized as poor (70%), good (70% to 79%), very good (80% to 89%), or excellent (90%). was considered as having substantial agreement between health technologist and researcher as indicated by 0.61 to 0.80; almost perfect agreement: 0.81 to Part II A 10% random sample of charts, which included all available diagnostic positions, was drawn from the sampling frame. The sample size was estimated to provide, on average, a 10% 95% CI width without adjustment to allow for multiple comparisons. Source documents, namely physician history and physical examination notes, physician progress notes, discharge summaries, nursing notes, and laboratory, echocardiogram, and ECG reports were reviewed systematically for atrial fibrillation, coronary artery disease/ischemic heart disease, diabetes mellitus, history of cerebrovascular accident, hypertension, hyperlipidemia, renal failure, and tobacco use. Codes were assigned only to those risk factors that fulfilled the diagnostic criteria as outlined in Table 2. Criteria were investigator derived, on the basis of current medical guidelines. Using the gold standard, the sensitivity, specificity, and percent correct of hospital health technologist coding of these stroke risk factors using and were calculated and compared.

3 1778 Stroke August 2005 TABLE 2. Criteria and Indicators for Chart Review Diagnosis of Stroke Risk Factors Risk Factor Criteria Indicators Atrial fibrillation Paroxysmal or chronic AFIB History, ECG, holter monitoring Coronary artery disease/ischemic heart disease Angina, myocardial infarction, or coronary atherosclerosis Angioplasty, stenting, CABG, ECHO, medication Diabetes mellitus Type 1 diabetes or type 2 diabetes Fasting blood glucose History, medication, lab results 7.0 mmol/l (126 mg/dl) History of cerebrovascular disease Stroke, TIA, stroke(s), or TIA(s) History, imaging reports, medication Hyperlipidemia Total cholesterol 5.0 mmol/l (193 mg/dl), LDL cholesterol 3.0 mmol/l (116 mg/dl) lipoprotein analysis done after a 9- to 12-hour fast History, medication Hypertension Without diabetes: systolic BP 140 mm Hg; diastolic BP 90 mm Hg. With diabetes: systolic BP 135 mm Hg; diastolic BP 85 mm Hg History, blood pressure readings in the nonacute phase, 1 week from admission, average of 2 readings on 2 visits after initial presentation, medication Renal failure Serum creatinine 100 mmol/l (1.1 mg/dl) Hemodialysis, peritoneal dialysis, medication Tobacco use Ex-smoker (daily for 1 year) or current smoker History AFIB indicates atrial fibrillation; CABG, coronary artery bypass grafting; LDL, low-density lipoprotein; BP, blood pressure; ECHO, echocardiography. Results Part I A total of 461 charts from 2000/2001 () and 256 from 2002/2003 () were randomly selected for review. The median age of patients was 71 (interquartile range [IQR], 59 to 80), and 50.6% were female. The level of agreement for stroke coding and the rate of correct coding of stroke type by coding scheme and type of hospital are listed in Table 3. The assessment of correct coding was based on clinical data alone in 24.3% of charts (no neurovascular imaging was done, or no imaging reports were available for review) and on clinical data and neurovascular imaging reports in 75.6% of charts. On the whole, coding was excellent with 90% (CI 95, 86 to 92) correct; 0.86 (CI 95, 0.81 to 0.91). was TABLE 3. PPV and Agreement of Stroke Type Coding by ICD Coding and Hospital Site similarly good with 92% (CI 95, 88 to 95) of strokes correctly coded; 0.89 (CI 95, 0.82 to 0.96). was not better than ; P TIA was correctly coded 97% of the time (CI to 99) compared with 70% (CI to 82) with ; P The range of coding errors was largely as expected, with stroke types confused with one another, notably TIA for AIS and ICH for SAH (Table 4). We found that the use of the modifier codes (fourth and fifth digit) in the excluded 95 cases of carotid endarterectomy that had not had an index stroke on the noted admission. This substantially increased the accuracy of coding for ischemic stroke when including code 433 in the stroke definition. At the hospital level, within each coding system, coding was nonsignificantly better using at 95% (CI 95,91to Stroke Type On Hospital Discharge Abstract Identified by Chart Review On Hospital Discharge Abstract Identified by Chart Review University hospital site 0.87 ( ) 0.93 ( ) AIS (78 91) (81 97) ICH ( ) (93)* SAH (89 99) (76 98) TIA (55 85) (90 99) Community hospital site 0.82 ( ) 0.71 ( ) AIS (70 94) (50 86) ICH (70 99) (70 99) SAH (29)* (16)* TIA (35 87) (52 99) All sites 0.86 ( ) 0.89 ( ) AIS (78 90) (76 92) ICH ( ) (92 99) SAH (90 99) (77 98) TIA (56 82) (88 99) *97.5% 1-sided lower CI.

4 Kokotailo and Hill Coding of Stroke Using and 1779 TABLE 4. Coding Errors by Stroke Type and ICD Coding No. Coding Based on Chart Review No. Coding Based on Chart Review Stroke Type AIS 18 (123)* 16-TIA 4-weakness unspecified 4-other 2-admitted to rehabilitation nonacutely 2 2-TIA 1-SAH 1-missing chart (95-admitted for elective carotid endarterectomy)* ICH AIS 3-SAH 1-missing chart SAH 3 2-ICH 1-admitted to rehabilitation nonacutely 1 1-ICH TIA 1 1-AIS 6 5-AIS 1-admitted to rehabilitation non-acutely *Carotid endarterectomy patients were identified correctly when using the fourth and fifth digits of the coding system. They were coded as vascular occlusion without infarct. They are included here to emphasize what the specific use of the fourth and fifth digits are in our sample. 98) accuracy at the university site compared with 80% (CI 95, 68 to 90) accuracy at the community sites (P0.503). Differences were less marked with (90% versus 89% accuracy; P0.883). Part II A total of 137 charts from 2000/2001 () and 112 from 2002/2003 () were randomly selected for review. The median age of patients was 73 (IQR, 65 to 81), and 49% were TABLE 5. Sensitivity, Specificity, PPV, and Agreement of Stroke Risk Factors by ICD Coding and Hospital Site Stroke Risk Factor Sensitivity Specificity Sensitivity Specificity University hospital site AFIB 73 (39 94) 99 ( ) 95 (87 99) 0.77 ( ) 100 (63)* 97 (90 99) 98 (91 99) 0.88 ( ) CAD/IHD 89 (71 98) 94 (83 99) 92 (84 97) 0.83 ( ) 86 (65 97) 97 (88 99) 94 (86 98) 0.84 ( ) DM 94 (69 99)3 98 (91 99) 98 (91 99) 0.92 ( ) 87 (66 97) 100 (94)* 96 (89 99) 0.91 ( ) History of CVA 44 (25 65) 100 (93)* 81 (70 89) 0.51 ( ) 48 (29 68) 93 (82 98) 78 (67 87) 0.45 ( ) Hyperlipidemia 70 (44 89) 98 (91 99) 92 (84 97) 0.75 ( ) 67 (51 81) 100 (91)* 83 (73 90) 0.67 ( ) Hypertension 84 (71 94) 88 (71 97) 86 (76 93) 0.72 ( ) 95 (85 99) 88 (67 97) 93 (84 97) 0.82 ( ) RF 50 (6 93) 99 ( ) 96 (89 99) 0.55 ( ) 66 (22 96) 100 (95)* 98 (91 99) 0.79 ( ) Tobacco use 0 (9) 98 (87 99) 52 (40 63) ( ) 25 (13 40) 100 (98)* 60 (48 71) 0.24 ( ) Community hospital sites AFIB 90 (55 99) 100 (92)* 98 (90 99) 0.94 ( ) 63 (24 91) 100 (83)* 90 (72 98) 0.71 ( ) CAD/IHD 77 (54 92) 83 (67 94) 81 (68 90) 0.60 ( ) 90 (55 99) 100 (82)* 97 (82 99) 0.92 ( ) DM 90 (66 99) 100 (90)* 97 (93)* 0.92 ( ) 100 (69)* 95 (73 99) 97 (82 99) 0.93 ( ) History of CVA 13 (3 30) 100 (87)* 53 (39 67) 0.12 ( ) 10 (0 44) 100 (82)* 69 (49 85) 0.13 ( ) Hyperlipidemia 36 (11 69) 100 (78)* 88 (76 95) 0.48 ( ) 40 (12 74) 100 (82)* 79 (60 92) 0.47 ( ) Hypertension 79 (63 90) 100 (78) 85 (72 93) 0.66 ( ) 74 (51 90) 67 (22 96) 72 (52 87) 0.33 ( ) RF 25 (3 65) 98 (89 99) 88 (77 95) 0.31 ( ) 50 (1 99) 96 (81 99) 93 (77 99) 0.46 ( ) Tobacco use 17 (4 37) 100 (89)* 66 (51 77) 0.19 ( ) 43 (9 81) 100 (84)* 86 (68 96) 0.53 ( ) All sites AFIB 81 (58 96) 99 ( ) 96 (91 99) 0.85 ( ) 98 (92 99) 96 (89 99) 98 (92 99) 0.81 ( ) CAD/IHD 84 (70 93) 90 (81 95) 88 (81 93) 0.73 ( ) 98 (4 19) 95 (88 98) 98 (4 19) 0.87 ( ) DM 91 (76 98) 99 ( ) 97 (92 99) 0.92 ( ) 99 ( ) 97 (91 99) 99 ( ) 0.91 ( ) History of CVA 28 (16 41) 100 (95)* 69 (61 77) 0.31 ( ) 95 (87 99) 76 (67 83) 95 (87 99) 0.37 ( ) Hyperlipidemia 57 (37 76) 99 ( ) 91 (84 95) 0.66 ( ) 100 (94)* 82 (74 89) 100 (94)* 0.63 ( ) Hypertension 82 (72 89) 92 (80 98) 85 (78 91) 0.70 ( ) 83 (65 94) 88 (79 93) 83 (65 94) 0.69 ( ) RF 33 (9 65) 98 (94 99) 93 (87 96) 0.41 ( ) 99 ( ) 96 (91 99) 99 ( ) 0.70 ( ) Tobacco use 7 (1 16) 99 ( ) 58 (48 66) 0.06 ( ) 100 (94)* 67 (57 76) 100 (94)* 0.29 ( ) AFIB indicates atrial fibrillation; CAD/IHD, coronary artery disease/ischemic heart disease; DM, diabetes mellitus; CVA, cerebrovascular accident; RF, renal failure. *97.5% 1-sided lower CI; 97.5% 1-sided upper CI.

5 1780 Stroke August 2005 female. Table 5 summarizes the sensitivity, specificity, and PPV of stroke risk factors according to ICD system and hospital site. Overall, coding of all risk factors was found to be similar between and. Global sensitivity was lower, with at 58% (CI 95, 52 to 63) compared with 67% (CI 95, 61 to 72); P Overall specificity was equal at 97% (CI 95, 96 to 98) compared with 97% (CI 95, 96 to 99); P Overall accuracy was similar at 84% (CI 95,82to 87) compared with 87% (CI 95, 84 to 89); P Characteristic of both schemes, atrial fibrillation, coronary artery disease/ischemic heart disease, diabetes mellitus, and hypertension coding was very good to excellent, showing a high degree of sensitivity and specificity. Conversely, coding of a history of cerebrovascular accident, hyperlipidemia, renal failure, and tobacco use ranged from poor to excellent, having quite low sensitivity but high specificity. The sensitivity improved only slightly for these risk factors with the switch to. These trends were observed at the hospital level. No differences were observed between the university and community hospital sites. Discussion Our data suggest that the administrative diagnoses of stroke and its risk factors are quite good and that no quantitative improvements have been realized with the switch to the system. Two caveats associated with using such data to make reliable conclusions are worth review. First, by definition, they apply only to hospital-based care. Therefore, data from those individuals who do not seek medical attention or who are only seen in outpatient clinic or offices are not captured. 2,11 For stroke, this results in a slight bias to more severe strokes because patients with only mild symptoms may not seek medical attention. This has been well demonstrated in Texas, where active and passive surveillance conducted concurrently showed that some cases were identified by active surveillance that were missed completely by the passive surveillance system. Interestingly, the converse was also true in that cases identified by passive surveillance were missed by the active surveillance system. 11 Second, administrative data depend on clerical staff interpreting the medical record and applying appropriate codes. Coding of stroke and its risk factors, like all hospital discharge abstract coding, depends on the quality of the data in the chart and the expertise of the coder. Charting is highly variable, and validation studies done in one setting may not apply across jurisdictions. We have shown previously that there exists wide variation in stroke coding using in rural compared with urban hospitals. 12 Rural hospitals tended to code stroke using more general codes, whereas urban coding was more specific. The centralization of stroke services and the establishment of an inpatient stroke unit, 13 as well as the training of a health records technologist at Foothills Medical Centre, may be 2 unique factors contributing to the results of our study. Our results concur with those of Goldstein, 8 who showed that a substantial minority of patients (15% to 20%) coded as having a stroke never had one. We used modifier codes (fourth and fifth digit in the system) to exclude patients who were admitted for carotid endarterectomy but had not had an index stroke on that admission. In the system for coding AIS, there are several codes that are described as acute arterial occlusion without infarct (433.00, , , , , and ). In our study, all 95 cases of elective carotid endarterectomy were coded as acute arterial occlusion without infarct. As suggested by Goldstein, these codes have particularly low accuracy for the diagnosis of true stroke. This problem does not occur with. The identification of stroke risk factors is more variable. Atrial fibrillation, coronary artery disease/ischemic heart disease, diabetes mellitus, and hypertension are identified with a high degree of confidence, whereas history of cerebrovascular disease, hyperlipidemia, renal failure, and tobacco use are identified to a lesser degree. The poor coding of the latter 4 risk factors may be attributable to poor charting by physicians and nursing staff, a lack of perceived importance by health technologist coders, or a lack of time to code everything. Education and understanding may help to improve this situation. The emergence of the electronic health record may allow automated and better coding of such risk factors within administrative databases. The system itself might benefit from the inclusion of more specific diagnostic codes for these comorbidities to improve their true diagnosis. However, the ability to reliably identify stroke risk factors among stroke patients using administrative data is an important addition to use of such data in health services research. Our study has notable limitations. We were unable to blind the chart reviewer to either the health records technologist coding or to which coding system was used because of practical limitations. Further, our system includes an active dialogue between the health records coder and the Calgary Stroke Team, meaning that our results may not be as generalizable to other jurisdictions. Our sampling frame was limited to those patients with stroke in the primary diagnostic position. Although this improves the specificity of diagnosis, it may limit sensitivity, implying that we may not have included patients with stroke in other diagnostic positions. Overall, our data provide evidence that stroke coding with is similar to. The greater clarity in definitions in the system may provide a qualitative advantage. Acknowledgments M.D.H. was supported by the Heart and Stroke Foundation of Alberta/NWT/Nunavut and the Canadian Institutes for Health Research. We would like to thank Chris Makar for her ongoing commitment to stroke coding. References 1. Yiannakoulias N, Svenson LW, Hill MD, Schopflocher DP, James RC, Wielgosz AT, Noseworthy TW. Regional comparisons of inpatient and outpatient patterns of cerebrovascular disease diagnosis in the province of Alberta. Chronic Dis Can. 2003;24: Truelsen T, Bonita R, Jamrozik K. Surveillance of stroke: a global perspective. Int J Epidemiol. 2001;30: Tirschwell DL, Longstreth WT Jr. Validating administrative data in stroke research. Stroke. 2002;33: Mayo NE, Goldberg MS, Levy AR, Danys I, Korner-Bitensky N. Changing rates of stroke in the province of Quebec, Canada: Stroke. 1991;22:

6 Kokotailo and Hill Coding of Stroke Using and Mayo NE, Neville D, Kirkland S, Ostbye T, Mustard CA, Reeder B, Joffres M, Brauer G, Levy AR. Hospitalization and case-fatality rates for stroke in Canada from 1982 through The Canadian Collaborative Study Group of Stroke Hospitalizations. Stroke. 1996;27: Ostbye T, Levy AR, Mayo NE. Hospitalization and case-fatality rates for subarachnoid hemorrhage in Canada from 1982 through The Canadian Collaborative Study Group of Stroke Hospitalizations. Stroke. 1997;28: Reker DM, Hamilton BB, Duncan PW, Yeh SC, Rosen A. Stroke: who s counting what? J Rehabil Res Dev. 2001;38: Goldstein LB. Accuracy of -CM coding for the identification of patient with acute ischemic stroke: effect of modifier codes. Stroke. 1998;29: Benesch C, Witter DM Jr, Wilder AL, Ducan PW, Samsa GP, Matchar DB. Inaccuracy of the International Classification of Diseases (-CM) in identifying the diagnosis of ischemic cerebrovascular disease. Neurology. 1997;49: Leibson CL, Naessens JM, Brown RD, Whisnant MD. Accuracy of hospital discharge abstracts for identifying stroke. Stroke. 1994;25: Piriyawat P, Smajsova M, Smith MA, Pallegar S, Al-Wabil A, Garcia NM, Risser JM, Moye LA, Morgenstern LB. Comparison of active and passive surveillance for cerebrovascular disease: the Brain Attack Surveillance in Corpus Christi (BASIC) Project. Am J Epidemiol. 2002;156: Yiannakoulias N, Svenson LW, Hill MD, Schopflocher DP, Rowe BH, James RC, Wielgosz AT, Noseworthy TW. Incident cerebrovascular disease in rural and urban Alberta. Cerebrovasc Dis. 2004;17: Field TS, Green TL, Roy K, Pederson J, Hill MD. Trends in stroke occurrence in Calgary. Can J Neurol. 2004;31:

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Inohara T, Xian Y, Liang L, et al. Association of intracerebral hemorrhage among patients taking non vitamin K antagonist vs vitamin K antagonist oral anticoagulants with in-hospital

More information

List of Exhibits Adult Stroke

List of Exhibits Adult Stroke List of Exhibits Adult Stroke List of Exhibits Adult Stroke i. Ontario Stroke Audit Hospital and Patient Characteristics Exhibit i. Hospital characteristics from the Ontario Stroke Audit, 200/ Exhibit

More information

Canadian Best Practice Recommendations for Stroke Care. (Updated 2008) Section # 3 Section # 3 Hyperacute Stroke Management

Canadian Best Practice Recommendations for Stroke Care. (Updated 2008) Section # 3 Section # 3 Hyperacute Stroke Management Canadian Best Practice Recommendations for Stroke Care (Updated 2008) Section # 3 Section # 3 Hyperacute Stroke Management Reorganization of Recommendations 2008 2006 RECOMMENDATIONS: 2008 RECOMMENDATIONS:

More information

Redgrave JN, Coutts SB, Schulz UG et al. Systematic review of associations between the presence of acute ischemic lesions on

Redgrave JN, Coutts SB, Schulz UG et al. Systematic review of associations between the presence of acute ischemic lesions on 6. Imaging in TIA 6.1 What type of brain imaging should be used in suspected TIA? 6.2 Which patients with suspected TIA should be referred for urgent brain imaging? Evidence Tables IMAG1: After TIA/minor

More information

Critical Review Form Therapy

Critical Review Form Therapy Critical Review Form Therapy A transient ischaemic attack clinic with round-the-clock access (SOS-TIA): feasibility and effects, Lancet-Neurology 2007; 6: 953-960 Objectives: To evaluate the effect of

More information

Cardiovascular Diseases and Diabetes

Cardiovascular Diseases and Diabetes Cardiovascular Diseases and Diabetes LEARNING OBJECTIVES Ø Identify the components of the cardiovascular system and the various types of cardiovascular disease Ø Discuss ways of promoting cardiovascular

More information

There is little information available about stroke risk after

There is little information available about stroke risk after Stroke Risk After Transient Ischemic Attack in a Population-Based Setting Lynda D. Lisabeth, PhD; Jennifer K. Ireland, MD; Jan M.H. Risser, PhD; Devin L. Brown, MD; Melinda A. Smith, MPH; Nelda M. Garcia,

More information

Secular Trends in Cardiovascular Disease in Kidney Transplant Recipients: 1994 to 2009

Secular Trends in Cardiovascular Disease in Kidney Transplant Recipients: 1994 to 2009 Western University Scholarship@Western Electronic Thesis and Dissertation Repository June 2015 Secular Trends in Cardiovascular Disease in Kidney Transplant Recipients: 1994 to 2009 Ngan Lam The University

More information

Emergency Department Stroke Registry Process of Care Indicator Specifications (July 1, 2011 June 30, 2012 Dates of Service)

Emergency Department Stroke Registry Process of Care Indicator Specifications (July 1, 2011 June 30, 2012 Dates of Service) Specifications Description Methodology NIH Stroke Scale (NIHSS) Performed in Initial Evaluation used to assess the percentage of adult stroke patients who had the NIHSS performed during their initial evaluation

More information

Stroke is the fourth-leading cause of death, the most common

Stroke is the fourth-leading cause of death, the most common Positive Predictive Values of ICD-9 Codes to Identify Patients With Stroke or TIA Kari L. Olson, BSc(Pharm), PharmD; Michele D. Wood, PharmD; Thomas Delate, PhD; Lisa J. Lash, PharmD; Jon Rasmussen, PharmD;

More information

Emergency Department Stroke Registry Indicator Specifications 2018 Report Year (07/01/2017 to 06/30/2018 Discharge Dates)

Emergency Department Stroke Registry Indicator Specifications 2018 Report Year (07/01/2017 to 06/30/2018 Discharge Dates) 2018 Report Year (07/01/2017 to 06/30/2018 Discharge Dates) Summary of Changes I62.9 added to hemorrhagic stroke ICD-10-CM diagnosis code list (table 3) Measure Description Methodology Rationale Measurement

More information

Transient Atrial Fibrillation and Risk of Stroke after Acute Myocardial Infarction

Transient Atrial Fibrillation and Risk of Stroke after Acute Myocardial Infarction Transient Atrial Fibrillation and Risk of Stroke after Acute Myocardial Infarction Doron Aronson MD, Gregory Telman MD, Fadel BahouthMD, Jonathan Lessick MD, DSc and Rema Bishara MD Department of Cardiology

More information

HEART AND SOUL STUDY OUTCOME EVENT - MORBIDITY REVIEW FORM

HEART AND SOUL STUDY OUTCOME EVENT - MORBIDITY REVIEW FORM REVIEW DATE REVIEWER'S ID HEART AND SOUL STUDY OUTCOME EVENT - MORBIDITY REVIEW FORM : DISCHARGE DATE: RECORDS FROM: Hospitalization ER Please check all that may apply: Myocardial Infarction Pages 2, 3,

More information

Table 1 Baseline characteristics of 60 hemodialysis patients with atrial fibrillation and warfarin use

Table 1 Baseline characteristics of 60 hemodialysis patients with atrial fibrillation and warfarin use Table 1 Baseline characteristics of 60 hemodialysis patients with atrial fibrillation and warfarin use Baseline characteristics Users (n = 28) Non-users (n = 32) P value Age (years) 67.8 (9.4) 68.4 (8.5)

More information

Table S1: Diagnosis and Procedure Codes Used to Ascertain Incident Hip Fracture

Table S1: Diagnosis and Procedure Codes Used to Ascertain Incident Hip Fracture Technical Appendix Table S1: Diagnosis and Procedure Codes Used to Ascertain Incident Hip Fracture and Associated Surgical Treatment ICD 9 Code Descriptions Hip Fracture 820.XX Fracture neck of femur 821.XX

More information

HAAD quality KPI; waiting time

HAAD quality KPI; waiting time Type: Waiting Time Indicator Indicator Number: WT001 Primary Care Appointment- Outpatient Setting Time to see a HAAD licensed family physician or member of their team (GP) Time of request (walk-in or by

More information

Lecture 8 Cardiovascular Health Lecture 8 1. Introduction 2. Cardiovascular Health 3. Stroke 4. Contributing Factors

Lecture 8 Cardiovascular Health Lecture 8 1. Introduction 2. Cardiovascular Health 3. Stroke 4. Contributing Factors Lecture 8 Cardiovascular Health 1 Lecture 8 1. Introduction 2. Cardiovascular Health 3. Stroke 4. Contributing Factors 1 Human Health: What s Killing Us? Health in America Health is the U.S Average life

More information

Asthma J45.20 Mild, uncomplicated J45.21 Mild, with (acute) exacerbation J45.22 Mild, with status asthmaticus

Asthma J45.20 Mild, uncomplicated J45.21 Mild, with (acute) exacerbation J45.22 Mild, with status asthmaticus A Fib & Flutter I48.0 Paroxysmal atrial fibrillation I48.1 Persistent atrial fibrillation I48.2 Chronic atrial fibrillation I48.3 Typical atrial flutter Asthma J45.20 Mild, uncomplicated J45.21 Mild, with

More information

Clinical Features and Subtypes of Ischemic Stroke Associated with Peripheral Arterial Disease

Clinical Features and Subtypes of Ischemic Stroke Associated with Peripheral Arterial Disease Cronicon OPEN ACCESS EC NEUROLOGY Research Article Clinical Features and Subtypes of Ischemic Stroke Associated with Peripheral Arterial Disease Jin Ok Kim, Hyung-IL Kim, Jae Guk Kim, Hanna Choi, Sung-Yeon

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Wolters FJ, Li L, Gutnikov SA, Mehta Z, Rothwell PM. Medical attention seeking after transient ischemic attack and minor stroke in relation to the UK Face, Arm, Speech, Time

More information

Standards of excellence

Standards of excellence The Accreditation Canada Stroke Distinction program was launched in March 2010 to offer a rigorous and highly specialized process above and beyond the requirements of Qmentum. The comprehensive Stroke

More information

Prevalence of cerebrovascular accidents (CVA) in obese hypertensives among inpatients of Govt.General Hospital, Guntur

Prevalence of cerebrovascular accidents (CVA) in obese hypertensives among inpatients of Govt.General Hospital, Guntur Original article Prevalence of cerebrovascular accidents (CVA) in obese hypertensives among inpatients of Govt.General Hospital, Guntur 1 Dr. Dr.Uday Shankar Sanakayala, 2 Dr. T. V. Adi Seshu Babu, 3 Dr.

More information

BMJ Open. Health services research. Keywords: Transient ischemic attack, Emergency medicine, Administrative data

BMJ Open. Health services research. Keywords: Transient ischemic attack, Emergency medicine, Administrative data A cohort study on physician documentation and the accuracy of administrative data coding to improve passive surveillance of transient ischemic attacks Journal: Manuscript ID bmjopen-0-0 Article Type: Research

More information

JAWDA Quarterly Waiting Time Guidelines for (Specialized and General Hospitals)

JAWDA Quarterly Waiting Time Guidelines for (Specialized and General Hospitals) JAWDA Waiting Time Guidelines for (Specialized and General Hospitals) January 2019 Page 1 of 22 Table of Contents Executive Summary... 3 About this Guidance... 4 Performance Indicators... 5 APPENDIX -

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Leibowitz M, Karpati T, Cohen-Stavi CJ, et al. Association between achieved low-density lipoprotein levels and major adverse cardiac events in patients with stable ischemic

More information

USRDS UNITED STATES RENAL DATA SYSTEM

USRDS UNITED STATES RENAL DATA SYSTEM USRDS UNITED STATES RENAL DATA SYSTEM Chapter 9: Cardiovascular Disease in Patients With ESRD Cardiovascular disease is common in ESRD patients, with atherosclerotic heart disease and congestive heart

More information

Malmö Preventive Project. Cardiovascular Endpoints

Malmö Preventive Project. Cardiovascular Endpoints Malmö Preventive Project Department of Clinical Sciences Skåne University Hospital, Malmö Lund University Malmö Preventive Project Cardiovascular Endpoints End of follow-up: 31 December Report: 9 March

More information

<INSERT COUNTRY/SITE NAME> All Stroke Events

<INSERT COUNTRY/SITE NAME> All Stroke Events WHO STEPS STROKE INSTRUMENT For further guidance on All Stroke Events, see Section 5, page 5-15 All Stroke Events Patient Identification and Patient Characteristics (I 1) Stroke

More information

Hypertension is rising in prevalence and contributes

Hypertension is rising in prevalence and contributes The Use of Claims Data Algorithms to Recruit Eligible Participants Into Clinical Trials Leonardo Tamariz, MD, MPH; Ana Palacio, MD, MPH; Jennifer Denizard, RN; Yvonne Schulman, MD; and Gabriel Contreras,

More information

Malmö Diet and Cancer Study incl. CV-cohort. Cardiovascular Endpoints

Malmö Diet and Cancer Study incl. CV-cohort. Cardiovascular Endpoints The Malmö Diet and Cancer Study Department of Clinical Sciences Skåne University Hospital, Malmö Lund University Malmö Diet and Cancer Study incl. CV-cohort Cardiovascular Endpoints End of follow-up: 31

More information

Chapter 9: Cardiovascular Disease in Patients With ESRD

Chapter 9: Cardiovascular Disease in Patients With ESRD Chapter 9: Cardiovascular Disease in Patients With ESRD Cardiovascular disease is common in adult ESRD patients, with atherosclerotic heart disease and congestive heart failure being the most common conditions

More information

The Impact of Smoking on Acute Ischemic Stroke

The Impact of Smoking on Acute Ischemic Stroke Smoking The Impact of Smoking on Acute Ischemic Stroke Wei-Chieh Weng, M.D. Department of Neurology, Chang-Gung Memorial Hospital, Kee-Lung, Taiwan Smoking related mortality Atherosclerotic vascular disease

More information

THE NATIONAL QUALITY FORUM

THE NATIONAL QUALITY FORUM THE NATIONAL QUALITY FORUM National Voluntary Consensus Standards for Patient Outcomes Table of Measures Submitted-Phase 1 As of March 5, 2010 Note: This information is for personal and noncommercial use

More information

10/8/2018. Lecture 9. Cardiovascular Health. Lecture Heart 2. Cardiovascular Health 3. Stroke 4. Contributing Factor

10/8/2018. Lecture 9. Cardiovascular Health. Lecture Heart 2. Cardiovascular Health 3. Stroke 4. Contributing Factor Lecture 9 Cardiovascular Health 1 Lecture 9 1. Heart 2. Cardiovascular Health 3. Stroke 4. Contributing Factor 1 The Heart Muscular Pump The Heart Receives blood low pressure then increases the pressure

More information

2003 World Health Organization (WHO) / International Society of Hypertension (ISH) Statement on Management of Hypertension.

2003 World Health Organization (WHO) / International Society of Hypertension (ISH) Statement on Management of Hypertension. 2003 World Health Organization (WHO) / International Society of Hypertension (ISH) Statement on Management of Hypertension Writing Group: Background Hypertension worldwide causes 7.1 million premature

More information

KEEPING YOUR PATIENT OUT OF THE HOSPITAL BY PREVENTING A SECOND STROKE

KEEPING YOUR PATIENT OUT OF THE HOSPITAL BY PREVENTING A SECOND STROKE KEEPING YOUR PATIENT OUT OF THE HOSPITAL BY PREVENTING A SECOND STROKE Dr. Grant Stotts Staff Neurologist, Ottawa Hospital Director, Ottawa Stroke Program Medical Director, Champlain Regional Stroke Program

More information

a. Ischemic stroke An acute focal infarction of the brain or retina (and does not include anterior ischemic optic neuropathy (AION)).

a. Ischemic stroke An acute focal infarction of the brain or retina (and does not include anterior ischemic optic neuropathy (AION)). 12.0 Outcomes 12.1 Definitions 12.1.1 Neurologic Outcome Events a. Ischemic stroke An acute focal infarction of the brain or retina (and does not include anterior ischemic optic neuropathy (AION)). Criteria:

More information

TRANSIENT ISCHEMIC ATTACK (TIA)

TRANSIENT ISCHEMIC ATTACK (TIA) TRANSIENT ISCHEMIC ATTACK (TIA) AND MINOR STROKE Dr. Leanne K. Casaubon, MD MSc FRCPC Associate Professor, University of Toronto Director, TIA and Minor Stroke (TAMS) Unit University Health Network - Toronto

More information

Stroke Update. Lacunar 19% Thromboembolic 6% SAH 13% ICH 13% Unknown 32% Hemorrhagic 26% Ischemic 71% Other 3% Cardioembolic 14%

Stroke Update. Lacunar 19% Thromboembolic 6% SAH 13% ICH 13% Unknown 32% Hemorrhagic 26% Ischemic 71% Other 3% Cardioembolic 14% Stroke Update Michel Torbey, MD, MPH, FAHA, FNCS Medical Director, Neurovascular Stroke Center Professor Department of Neurology and Neurosurgery The Ohio State University Wexner Medical Center Objectives

More information

Alan Barber. Professor of Clinical Neurology University of Auckland

Alan Barber. Professor of Clinical Neurology University of Auckland Alan Barber Professor of Clinical Neurology University of Auckland Presented with L numbness & slurred speech 2 episodes; 10 mins & 2 hrs Hypertension Type II DM Examination P 80/min reg, BP 160/95, normal

More information

Comorbidity Level 1 Level 2 Level 3 Comments Reference Diabetes Yes Unknown

Comorbidity Level 1 Level 2 Level 3 Comments Reference Diabetes Yes Unknown Comorbidity Level 1 Level 2 Level 3 Comments Reference Diabetes HbA1c If medication; - Insulin - Oral antidiabetic - Both - Diet - treatment : Fasting blood sugar 7 mmol/l or post glucose 11.1 mmol/l and/or

More information

Changing Demographics in Death After Devastating Brain Injury

Changing Demographics in Death After Devastating Brain Injury Changing Demographics in Death After Devastating Brain Injury Andreas H. Kramer MD MSc FRCPC Departments of Critical Care Medicine & Clinical Neurosciences Foothills Medical Center, University of Calgary

More information

Ischaemic cardiovascular disease

Ischaemic cardiovascular disease Ischaemic cardiovascular disease What are the PHO performance programme indicators and how are they best achieved? 40 BPJ Issue 36 Supporting the PHO Performance Programme The PHO Performance Programme

More information

QUALITY OF STROKE CARE IN CANADA STROKE KEY QUALITY INDICATORS. Update 2016 AND STROKE CASE DEFINITIONS

QUALITY OF STROKE CARE IN CANADA STROKE KEY QUALITY INDICATORS. Update 2016 AND STROKE CASE DEFINITIONS QUALITY OF STROKE CARE IN CANADA STROKE KEY QUALITY INDICATORS AND STROKE CASE DEFINITIONS Update 2016 Canadian Stroke Best Practices Stroke Quality Advisory Committee 2016 Heart and Stroke Foundation

More information

DUKECATHR Dataset Dictionary

DUKECATHR Dataset Dictionary DUKECATHR Dataset Dictionary Version of DUKECATH dataset for educational use that has been modified to be unsuitable for clinical research or publication (Created Date and Time: 28OCT16 14:35) Table of

More information

Emergently? Michigan Institute for Neurological Disorders. Garden City Hospital, Garden City, Michigan

Emergently? Michigan Institute for Neurological Disorders. Garden City Hospital, Garden City, Michigan Why Should TIA be Treated Emergently? Anne M. Pawlak, D.O. F.A.C.N. Michigan Institute for Neurological Disorders Director Neurology Residency Program, Garden City Hospital, Garden City, Michigan According

More information

Implications Of Discordances Between Stroke Clinical Diagnoses And Icd-9-Cm Codes 2013 Data From The Paul Coverdell National Acute Stroke Program

Implications Of Discordances Between Stroke Clinical Diagnoses And Icd-9-Cm Codes 2013 Data From The Paul Coverdell National Acute Stroke Program Yale University EliScholar A Digital Platform for Scholarly Publishing at Yale Public Health Theses School of Public Health January 2015 Implications Of Discordances Between Stroke Clinical Diagnoses And

More information

Appendix This appendix was part of the submitted manuscript and has been peer reviewed. It is posted as supplied by the authors.

Appendix This appendix was part of the submitted manuscript and has been peer reviewed. It is posted as supplied by the authors. Appendix This appendix was part of the submitted manuscript and has been peer reviewed. It is posted as supplied by the authors. Appendix to: Banks E, Crouch SR, Korda RJ, et al. Absolute risk of cardiovascular

More information

Critical Review Form Therapy Objectives: Methods:

Critical Review Form Therapy Objectives: Methods: Critical Review Form Therapy Clinical Trial Comparing Primary Coronary Angioplasty with Tissue-Plasminogen Activator for Acute Myocardial Infarction (GUSTO-IIb), NEJM 1997; 336: 1621-1628 Objectives: To

More information

Safety of Single- Versus Multi-vessel Angioplasty for Patients with AMI and Multi-vessel CAD

Safety of Single- Versus Multi-vessel Angioplasty for Patients with AMI and Multi-vessel CAD Safety of Single- Versus Multi-vessel Angioplasty for Patients with AMI and Multi-vessel CAD Mun K. Hong, MD Associate Professor of Medicine Director, Cardiovascular Intervention and Research Weill Cornell

More information

Slide 1. Slide 2 Conflict of Interest Disclosure. Slide 3 Stroke Facts. The Treatment of Intracranial Stenosis. Disclosure

Slide 1. Slide 2 Conflict of Interest Disclosure. Slide 3 Stroke Facts. The Treatment of Intracranial Stenosis. Disclosure Slide 1 The Treatment of Intracranial Stenosis Helmi Lutsep, MD Vice Chair and Dixon Term Professor, Department of Neurology, Oregon Health & Science University Chief of Neurology, VA Portland Health Care

More information

Shawke A. Soueidan, MD. Riverside Neurology & Sleep Specialists

Shawke A. Soueidan, MD. Riverside Neurology & Sleep Specialists Shawke A. Soueidan, MD Riverside Neurology & Sleep Specialists 757-221-0110 Epidemiology of stroke 2018 Affects nearly 800,000 people in the US annually Approximately 600000 first-ever strokes and 185000

More information

Tennessee Department of Health in collaboration with Tennessee State University and University of Tennessee Health Science Center

Tennessee Department of Health in collaboration with Tennessee State University and University of Tennessee Health Science Center Tennessee Department of Health in collaboration with Tennessee State University and University of Tennessee Health Science Center 2006 Tennessee Department of Health 2006 ACKNOWLEDGEMENTS CONTRIBUTING

More information

Mortality following acute myocardial infarction (AMI) in

Mortality following acute myocardial infarction (AMI) in In-Hospital Mortality Among Patients With Type 2 Diabetes Mellitus and Acute Myocardial Infarction: Results From the National Inpatient Sample, 2000 2010 Bina Ahmed, MD; Herbert T. Davis, PhD; Warren K.

More information

Peripheral Arterial Occlusive Disease- The Challenge in patients with diabetes

Peripheral Arterial Occlusive Disease- The Challenge in patients with diabetes Peripheral Arterial Occlusive Disease- The Challenge in patients with diabetes Ashok Handa Reader in Surgery and Consultant Surgeon Nuffield Department of Surgery University of Oxford Introduction Vascular

More information

WHI Form Report of Cardiovascular Outcome Ver (For items 1-11, each question specifies mark one or mark all that apply.

WHI Form Report of Cardiovascular Outcome Ver (For items 1-11, each question specifies mark one or mark all that apply. WHI Form - Report of Cardiovascular Outcome Ver. 6. COMMENTS To be completed by Physician Adjudicator Date Completed: - - (M/D/Y) Adjudicator Code: OMB# 095-044 Exp: 4/06 -Affix label here- Clinical Center/ID:

More information

Stroke 101. Maine Cardiovascular Health Summit. Eileen Hawkins, RN, MSN, CNRN Pen Bay Stroke Program Coordinator November 7, 2013

Stroke 101. Maine Cardiovascular Health Summit. Eileen Hawkins, RN, MSN, CNRN Pen Bay Stroke Program Coordinator November 7, 2013 Stroke 101 Maine Cardiovascular Health Summit Eileen Hawkins, RN, MSN, CNRN Pen Bay Stroke Program Coordinator November 7, 2013 Stroke Statistics Definition of stroke Risk factors Warning signs Treatment

More information

Stroke Special Project 640 and 740 Resource For Health Information Management Professionals

Stroke Special Project 640 and 740 Resource For Health Information Management Professionals Stroke Special Project 640 and 740 Resource For Health Information Management Professionals Linda Gould RPN Erin Kelleher, BA, CHIM Stefan Pagliuso PT, B.A. Kin(Hon.) Overview of this Resource Overview

More information

MORTALITY AND MORBIDITY RISK FROM CAROTID ARTERY ATHEROSCLEROSIS. 73 year old NS right-handed male applicant for $1 Million life insurance

MORTALITY AND MORBIDITY RISK FROM CAROTID ARTERY ATHEROSCLEROSIS. 73 year old NS right-handed male applicant for $1 Million life insurance MORTALITY AND MORBIDITY RISK FROM CAROTID ARTERY ATHEROSCLEROSIS October 17, 2012 AAIM Triennial Conference, San Diego Robert Lund, MD What Is The Risk? 73 year old NS right-handed male applicant for $1

More information

Protecting the heart and kidney: implications from the SHARP trial

Protecting the heart and kidney: implications from the SHARP trial Cardiology Update, Davos, 2013: Satellite Symposium Protecting the heart and kidney: implications from the SHARP trial Colin Baigent Professor of Epidemiology CTSU, University of Oxford S1 First CTT cycle:

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Inohara T, Manandhar P, Kosinski A, et al. Association of renin-angiotensin inhibitor treatment with mortality and heart failure readmission in patients with transcatheter

More information

ANNEX FORM TO EXAMINE THE CAUSES OF ESRD I IDENTIFICATION. 1 Record number (patient chart) Name. 1.1 Date of birth / / 1.2 Sex:

ANNEX FORM TO EXAMINE THE CAUSES OF ESRD I IDENTIFICATION. 1 Record number (patient chart) Name. 1.1 Date of birth / / 1.2 Sex: Supplementary Material from Prevalence of clinically validated primary causes of end-stage renal disease (ESRD) in a State Capital in Northeastern Brazil ANNEX FORM TO EXAMINE THE CAUSES OF ESRD I IDENTIFICATION

More information

GWTG Post-Discharge Follow-up Form

GWTG Post-Discharge Follow-up Form Bold font = Required field Patient ID: Date of Hospital Admission: / / mm / dd / yyyy Date Follow-up Completed: / / mm / dd / yyyy PATIENT LOGISTICS Method used for Patient follow-up: Chart Review Health

More information

MORTALITY AND MORBIDITY RISK FROM CAROTID ARTERY ATHEROSCLEROSIS. 73 year old NS right-handed male applicant for $1 Million Life Insurance

MORTALITY AND MORBIDITY RISK FROM CAROTID ARTERY ATHEROSCLEROSIS. 73 year old NS right-handed male applicant for $1 Million Life Insurance MORTALITY AND MORBIDITY RISK FROM CAROTID ARTERY ATHEROSCLEROSIS October 17, 2012 AAIM Triennial Conference, San Diego Robert Lund, MD What Is The Risk? 73 year old NS right-handed male applicant for $1

More information

Stroke Net Grand Round Webinar

Stroke Net Grand Round Webinar Stroke Net Grand Round Webinar Preconditioning the Brain for Stroke Prevention April 4, 2019 Sebastian Koch University of Miami Department of Neurology None Unique challenges in brain conditioning Review

More information

Nicolas Bianchi M.D. May 15th, 2012

Nicolas Bianchi M.D. May 15th, 2012 Nicolas Bianchi M.D. May 15th, 2012 New concepts in TIA Differential Diagnosis Stroke Syndromes To learn the new definitions and concepts on TIA as a condition of high risk for stroke. To recognize the

More information

ESC Congress 2011 SIMULTANEOUS HYBRID REVASCULARIZATION OF CAROTID AND CORONARY DISEASE INITIAL RESULTS OF A NEW THERAPEUTIC APPROACH

ESC Congress 2011 SIMULTANEOUS HYBRID REVASCULARIZATION OF CAROTID AND CORONARY DISEASE INITIAL RESULTS OF A NEW THERAPEUTIC APPROACH ESC Congress 2011 SIMULTANEOUS HYBRID REVASCULARIZATION OF CAROTID AND CORONARY DISEASE IN PATIENTS WITH ACUTE CORONARY SYNDROME: INITIAL RESULTS OF A NEW THERAPEUTIC APPROACH AUTHORS: Marta Ponte 1, RICARDO

More information

4/7/ The stats on heart disease. + Deaths & Age-Adjusted Death Rates for

4/7/ The stats on heart disease. + Deaths & Age-Adjusted Death Rates for + Update on Lipid Management Stacey Gardiner, MD Assistant Professor Division of Cardiovascular Medicine Medical College of Wisconsin + The stats on heart disease Over the past 10 years for which statistics

More information

Rehospitalization for Stroke among Elderly TIA Patients

Rehospitalization for Stroke among Elderly TIA Patients Rehospitalization for Stroke among Elderly TIA Patients By William Buczko, PhD Centers for Medicare & Medicaid Services 7500 Security Blvd. C3-19-07 Baltimore, MD 21244-1850 Email: WBuczko@CMS.HHS.gov

More information

Therapy for Acute Stroke. Systems of Care for TIA

Therapy for Acute Stroke. Systems of Care for TIA Therapy for Acute Stroke and Systems of Care for TIA Gregory W. Albers, MD Coyote Foundation Professor of Neurology and Neurological Sciences Director, Stanford Stroke Center Stanford University Medical

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Guimarães PO, Krishnamoorthy A, Kaltenbach LA, et al. Accuracy of medical claims for identifying cardiovascular and bleeding events after myocardial infarction: a secondary

More information

Antithrombotic therapy in patients with transient ischemic attack / stroke (acute phase <48h)

Antithrombotic therapy in patients with transient ischemic attack / stroke (acute phase <48h) Antithrombotic therapy in patients with transient ischemic attack / stroke (acute phase

More information

Impact of a Stroke Unit on Length of Hospital Stay and In-Hospital Case Fatality

Impact of a Stroke Unit on Length of Hospital Stay and In-Hospital Case Fatality Impact of a Stroke Unit on Length of Hospital Stay and In-Hospital Case Fatality Hai Feng Zhu, MD, MSc; Nancy N. Newcommon, RN, MN; Mary Elizabeth Cooper, RN, MN; Teri L. Green, RN, PhD; Barbara Seal,

More information

Each year, more than Americans have a stroke

Each year, more than Americans have a stroke Characteristics, Performance Measures, and In-Hospital Outcomes of the First One Million Stroke and Transient Ischemic Attack Admissions in Get With The Guidelines-Stroke Gregg C. Fonarow, MD; Mathew J.

More information

CVD Prevention, Who to Consider

CVD Prevention, Who to Consider Continuing Professional Development 3rd annual McGill CME Cruise September 20 27, 2015 CVD Prevention, Who to Consider Dr. Guy Tremblay Excellence in Health Care and Lifelong Learning Global CV risk assessment..

More information

The MAIN-COMPARE Registry

The MAIN-COMPARE Registry Long-Term Outcomes of Coronary Stent Implantation versus Bypass Surgery for the Treatment of Unprotected Left Main Coronary Artery Disease Revascularization for Unprotected Left MAIN Coronary Artery Stenosis:

More information

Lessons from the Development of a Canadian National System of Surveillance

Lessons from the Development of a Canadian National System of Surveillance Lessons from the Development of a Canadian National System of Surveillance NATHALIE JETTÉ MD, MSc, FRCPC Assistant Professor Neurology Hotchkiss Brain Institute Calgary Institute of Population and Public

More information

Ministry of Health. BC Chronic Disease and Selected Procedure Case Definitions. Chronic Disease Information Working Group. Date Created: June 29, 2015

Ministry of Health. BC Chronic Disease and Selected Procedure Case Definitions. Chronic Disease Information Working Group. Date Created: June 29, 2015 Ministry of Health BC Chronic Disease and Selected Procedure Case Definitions Author: Chronic Disease Information Working Group Date Created: June 29, 2015 Last Updated: February 01, 2018 Version: Email:

More information

Alan Barber. Professor of Clinical Neurology University of Auckland

Alan Barber. Professor of Clinical Neurology University of Auckland Alan Barber Professor of Clinical Neurology University of Auckland Presented with L numbness & slurred speech 2 episodes; 10 mins & 2 hrs Hypertension Type II DM Examination pulse 80/min reg, BP 160/95

More information

Andrew Cohen, MD and Neil S. Skolnik, MD INTRODUCTION

Andrew Cohen, MD and Neil S. Skolnik, MD INTRODUCTION 2 Hyperlipidemia Andrew Cohen, MD and Neil S. Skolnik, MD CONTENTS INTRODUCTION RISK CATEGORIES AND TARGET LDL-CHOLESTEROL TREATMENT OF LDL-CHOLESTEROL SPECIAL CONSIDERATIONS OLDER AND YOUNGER ADULTS ADDITIONAL

More information

COMPREHENSIVE SUMMARY OF INSTOR REPORTS

COMPREHENSIVE SUMMARY OF INSTOR REPORTS COMPREHENSIVE SUMMARY OF INSTOR REPORTS Please note that the following chart provides a sampling of INSTOR reports to differentiate this registry s capabilities as a process improvement system. This list

More information

Patient characteristics Intervention Comparison Length of followup

Patient characteristics Intervention Comparison Length of followup ISCHAEMIA TESTING CHAPTER TESTING FOR MYCOCARDIAL ISCHAEMIA VERSUS NOT TESTING FOR MYOCARDIAL ISCHAEMIA Ref ID: 4154 Reference Wienbergen H, Kai GA, Schiele R et al. Actual clinical practice exercise ing

More information

Candesartan Antihypertensive Survival Evaluation in Japan (CASE-J) Trial of Cardiovascular Events in High-Risk Hypertensive Patients

Candesartan Antihypertensive Survival Evaluation in Japan (CASE-J) Trial of Cardiovascular Events in High-Risk Hypertensive Patients 1/5 This site became the new ClinicalTrials.gov on June 19th. Learn more. We will be updating this site in phases. This allows us to move faster and to deliver better services. Show less IMPORTANT: Listing

More information

Sheffield guidelines for the use of antiplatelets in the prevention and treatment of cardiovascular disease (October 2017)

Sheffield guidelines for the use of antiplatelets in the prevention and treatment of cardiovascular disease (October 2017) Sheffield guidelines f the use of antiplatelets in the prevention and treatment of cardiovascular disease (October 2017) Approved by Sheffield Area Prescribing Committee and Sheffield Teaching Hospitals

More information

Chapter 4: Cardiovascular Disease in Patients With CKD

Chapter 4: Cardiovascular Disease in Patients With CKD Chapter 4: Cardiovascular Disease in Patients With CKD Introduction Cardiovascular disease is an important comorbidity for patients with chronic kidney disease (CKD). CKD patients are at high-risk for

More information

The MAIN-COMPARE Study

The MAIN-COMPARE Study Long-Term Outcomes of Coronary Stent Implantation versus Bypass Surgery for the Treatment of Unprotected Left Main Coronary Artery Disease Revascularization for Unprotected Left MAIN Coronary Artery Stenosis:

More information

PFO Management update

PFO Management update PFO Management update May 12, 2017 Peter Casterella, MD Swedish Heart and Vascular 1 PFO Update 2017: Objectives Review recently released late outcomes of RESPECT trial and subsequent FDA approval of PFO

More information

Ticagrelor compared with clopidogrel in patients with acute coronary syndromes the PLATO trial

Ticagrelor compared with clopidogrel in patients with acute coronary syndromes the PLATO trial compared with clopidogrel in patients with acute coronary syndromes the PLATO trial August 30, 2009 at 08.00 CET PLATO background In NSTE-ACS and STEMI, current guidelines recommend 12 months aspirin and

More information

THE FRAMINGHAM STUDY Protocol for data set vr_soe_2009_m_0522 CRITERIA FOR EVENTS. 1. Cardiovascular Disease

THE FRAMINGHAM STUDY Protocol for data set vr_soe_2009_m_0522 CRITERIA FOR EVENTS. 1. Cardiovascular Disease THE FRAMINGHAM STUDY Protocol for data set vr_soe_2009_m_0522 CRITERIA FOR EVENTS 1. Cardiovascular Disease Cardiovascular disease is considered to have developed if there was a definite manifestation

More information

Acute Coronary Syndrome

Acute Coronary Syndrome ACUTE CORONOARY SYNDROME, ANGINA & ACUTE MYOCARDIAL INFARCTION Administrative Consultant Service 3/17 Acute Coronary Syndrome Acute Coronary Syndrome has evolved as a useful operational term to refer to

More information

Lipids Testing

Lipids Testing Previously Listed as Edit 12 190.23 - Lipids Testing Lipoproteins are a class of heterogeneous particles of varying sizes and densities containing lipid and protein. These lipoproteins include cholesterol

More information

Ischemic Heart Disease Mortality, Morbidity and Risk Factors of Coronary Care Unit Patients

Ischemic Heart Disease Mortality, Morbidity and Risk Factors of Coronary Care Unit Patients Ischemic Heart Disease Mortality, Morbidity and Risk Factors of Coronary (MBCHB, DM, FICMS) 1 Abstract Background: Ischemic heart disease (IHD) is the commonest type of heart disease.it causes more deaths

More information

Blood Pressure Reduction Among Acute Stroke Patients A Randomized Controlled Clinical Trial

Blood Pressure Reduction Among Acute Stroke Patients A Randomized Controlled Clinical Trial Blood Pressure Reduction Among Acute Stroke Patients A Randomized Controlled Clinical Trial Jiang He, Yonghong Zhang, Tan Xu, Weijun Tong, Shaoyan Zhang, Chung-Shiuan Chen, Qi Zhao, Jing Chen for CATIS

More information

Common Repatha Documentation Requirements for Patients With Primary Hyperlipidemia and Established CVD 1,2

Common Repatha Documentation Requirements for Patients With Primary Hyperlipidemia and Established CVD 1,2 Established CVD Common Repatha Documentation Requirements for Patients With Primary Hyperlipidemia and Established CVD 1,2 Primary and Secondary Diagnosis Codes Primary Diagnosis: Primary hyperlipidemia

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Kavousi M, Leening MJG, Nanchen D, et al. Comparison of application of the ACC/AHA guidelines, Adult Treatment Panel III guidelines, and European Society of Cardiology guidelines

More information

The American Experience

The American Experience The American Experience Jay F. Piccirillo, MD, FACS, CPI Department of Otolaryngology Washington University School of Medicine St. Louis, Missouri, USA Acknowledgement Dorina Kallogjeri, MD, MPH- Senior

More information

CORONARY ARTERY BYPASS GRAFT (CABG) MEASURES GROUP OVERVIEW

CORONARY ARTERY BYPASS GRAFT (CABG) MEASURES GROUP OVERVIEW CONARY ARTERY BYPASS GRAFT (CABG) MEASURES GROUP OVERVIEW 2015 PQRS OPTIONS F MEASURES GROUPS: 2015 PQRS MEASURES IN CONARY ARTERY BYPASS GRAFT (CABG) MEASURES GROUP: #43 Coronary Artery Bypass Graft (CABG):

More information

Supplement Table 1. Definitions for Causes of Death

Supplement Table 1. Definitions for Causes of Death Supplement Table 1. Definitions for Causes of Death 3. Cause of Death: To record the primary cause of death. Record only one answer. Classify cause of death as one of the following: 3.1 Cardiac: Death

More information

Hospitalization Resource Use and Costs Before and After TIA and Stroke: Results from a Population-Based Cohort Study (OXVASC)

Hospitalization Resource Use and Costs Before and After TIA and Stroke: Results from a Population-Based Cohort Study (OXVASC) VALUE IN HEALTH 16 (2013) 280 287 Available online at www.sciencedirect.com journal homepage: www.elsevier.com/locate/jval Hospitalization Resource Use and Costs Before and After TIA and Stroke: Results

More information